A Multi-Center Study of the Prevalence and Characteristics of Eosinophilic Phenotype and High IgE Levels Among Chinese Patients with Severe Asthma [Corrigendum]

This article refers to:

A Multi-Center Study of the Prevalence and Characteristics of Eosinophilic Phenotype and High IgE Levels Among Chinese Patients with Severe Asthma

Ko FWS, Wang JKL, Hui DSC, et al. J Asthma Allergy. 2023;16:173-182.

The authors have advised there is an error in Table 1.

Table 1 on Page 177, in the third-to-last row, data addressing Median (IQR) for Eosinophil count, cells/mm³ should read from 3.2 (1.7, 6.0) to 240.0 (110.0, 410.0).

The authors apologize for this error.

Correct Table 1:

Table

Characteristic	N=232
Age, years, mean±SD	53.9±12.9
Sex, male, n (%)	86 (37.1)
Height, cm, mean±SD	161.3±8.7
Weight, kg, mean±SD	66.5±14.9
Body mass index, kg/m^2, mean±SD	25.5±5.3
Smoking history, n (%)
Active smoker	19 (8.2)
Former smoker	48 (20.7)
Never smoker	165 (71.1)
Duration of diagnosed asthma, years, mean±SD	26.2±15.7
Asthma diagnosed at <12 years of age, n (%)^a	71 (30.7)
Skin prick test, positive, n (%)^b	34 (73.9)
Comorbidities, n (%)
Rhinitis	156 (93.4)
Nasal polyps	17 (10.2)
Sinusitis	2 (1.2)
Atopic dermatitis	30 (18.0)
Asthma associated with NSAIDs	0 (0)
Aspergillosis	0 (0)
Eczema	13 (7.8)
Treatment, n (%)
ICS/LABA	232 (100)
LAMA	75 (39)
LTRA	154 (81)
Chronic OCS	8 (3.4)
Level of asthma symptom control, n (%)
Well-controlled	67 (29)
Partly controlled	92 (40)
Uncontrolled	73 (31)
Number of severe exacerbations in the last year, n (%)
0	175 (75)
1	28 (12)
2	10 (4)
3	9 (4)
>3	10 (4)
Lung function test^c
Pre-bronchodilator FEV1, L	2.0±0.8
Post-bronchodilator FEV1, L	2.0±0.6
Pre-bronchodilator % of the predicted FEV1 value, %	79.7±22.8
Post-bronchodilator % of the predicted FEV1 value, %	83.8±18.4
Pre-bronchodilator FEV1 / FVC, %	68.2±15.0
Post-bronchodilator FEV1 / FVC, %	71.0±13.2
Eosinophil count, cells/mm^3
Mean±SD	312.7±281.6
Median (IQR)	240.0 (110.0, 410.0)
% Eosinophil count, %
Mean±SD	4.3±3.7
Median (IQR)	3.2 (1.7, 6.0)
Total serum IgE, IU/mL
Mean±SD	390.5±912.2
Median (IQR)	123.0 (40.8, 371.5)

Notes: ^an=231; ^bn=46; ^cn=57.

Abbreviations: ICS, inhaled corticosteroid; IQR, interquartile range; LABA, long-acting β2 agonists; LAMA, long-acting muscarinic antagonists; LTRA, leukotriene receptor antagonists; OCS, oral corticosteroid; SD, standard deviation.